Stocks and dollar gain on U.S. retail sales, drug trial

Stocks and dollar gain on U.S. retail sales, drug trial

Reuters

Published

Risk appetite found new life on Tuesday on a record rebound in U.S. retail sales, fresh support from the Federal Reserve and Bank of Japan, and upbeat trial results for a COVID-19 treatment, driving global equity markets higher and boosting the dollar.

Full Article